🔍 RecallPedia

SHISEIDO AMERICA

5 recalls •

• Categories: Other Drugs

Shiseido Future Solution LX Universal Defense SPF 50+ (octinoxate 4.9%, octocrylebe 3.0%, oxybenzone 1.0% and zinc oxide 15.4%), packaged in a) 2mL, b) 15 mL and c) 50 mL tubes, Shiseido Americas Corporation Dist. New York, NY 10022. NDC 58411-256-60

Class I - Dangerous

GMP Deviations: manufacturing of API material did not meet GMP and quality requirements.

Dec 14, 2017 Other Drugs Nationwide View Details →

Shiseido Future Solution LX Discovery Set contains SPF 50+ (octinoxate 4.9%, octocrylebe 3.0%, oxybenzone 1.0% and zinc oxide 15.4%), packaged in 15 mL tubes, Shiseido Americas Corporation Dist. New York, NY 10022,

Class I - Dangerous

GMP Deviations: manufacturing of API material did not meet GMP and quality requirements.

Dec 14, 2017 Other Drugs Nationwide View Details →

bareMinerals Broad Spectrum SPF 50 Daily Prep Lotion (zinc oxide 23.8%, titanium dioxide 4.1%), 40 mL/1.35 fl. oz. bottle, Dist. by Bare Escentuals Beauty, Inc. SF, CA 94105 USA, NDC 98132-761-01

Class I - Dangerous

GMP Deviations: manufacturing of API material did not meet GMP and quality requirements.

Dec 14, 2017 Other Drugs Nationwide View Details →

Shiseido Future Solution LX Luxurious Eye & Lip Collection contains SPF 50+ (octinoxate 4.9%, octocrylebe 3.0%, oxybenzone 1.0% and zinc oxide 15.4%), packaged in 15 mL tubes, Shiseido Americas Corporation Dist. New York, NY 10022

Class I - Dangerous

GMP Deviations: manufacturing of API material did not meet GMP and quality requirements.

Dec 14, 2017 Other Drugs Nationwide View Details →

Shiseido Future Solutions LX Triple Points Bonus contains SPF 50+ (octinoxate 4.9%, octocrylebe 3.0%, oxybenzone 1.0% and zinc oxide 15.4%), packaged in 15 mL tubes, Shiseido Americas Corporation Dist. New York, NY 10022, NDC 58411-256-60

Class I - Dangerous

GMP Deviations: manufacturing of API material did not meet GMP and quality requirements.

Dec 14, 2017 Other Drugs Nationwide View Details →